Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, December 25, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Gainwell Technologies’s acquisition of HMS for $3.4 billion. HMS provides a broad range of payment accuracy and population health management solutions, as well as analytics and engagement solutions. Gainwell Technologies, a portfolio company of Veritas Capital, is the former U.S. State and Local Health and Human Services business of DXC... Read More »
Gainwell Technologies Acquires HMS
Gainwell Technologies, a portfolio company of Veritas Capital, has announced it acquired HMS (NASDAQ: HMSY). HMS provides a broad range of payment accuracy and population health management solutions, as well as analytics and engagement solutions. Under the terms of the agreement, Gainwell will buy HMS for $3.4 billion, or $37 per share in cash, a 52% premium to HMS’ unaffected share price as of October 2, 2020, the last trading day prior to when reports of a possible transaction were published. The purchase price comes out to 5.13x HMS’ 2020 annualized revenue and 22.60x HMS’ annualized EBITDA. Gainwell Technologies supports clients across the United States and territories with offerings... Read More »
EyeSouth Partners Adds Another Texas Physician Group
The private equity-backed EyeSouth Partners is closing 2020 on a strong note. With the support of Shore Capital Partners, EyeSouth Partners added Eye Center of Texas (ECT), which employs 14 physicians across six primary clinical locations in the greater Houston area and provides an integrated service model incorporating the latest advancements in cataract surgery, retina management, glaucoma treatment, refractive surgery and routine eye exams. EyeSouth Partners is an eye care services organization in the southeast. Its affiliate network consists of 114 doctors providing medical and surgical eye care services at approximately 70 locations, including 11 surgery centers, in Alabama, Florida,... Read More »
Servier Builds Oncology Portfolio With New Deal
The France-based pharmaceutical company Servier is back with a new deal, adding Agios Pharmaceuticals, Inc.‘s (NASDAQ: AGIO) oncology portfolio for $1.8 billion upfront in cash. The portfolio consists of Agios’ commercial, clinical and research-stage oncology product line, which includes Tibsovo, a treatment for adults with IDH1-mutant relapsed or refractory acute myeloid leukemia, and additional oncology pipeline and clinical programs. The deal also includes Agios’ co-commercialization responsibilities for Bristol Myers Squibb’s (NYSE: BMY) IDHIFA and certain clinical development activities within the IDHIFA development program. In addition to the upfront payment, Servier will pay Agios... Read More »
Cerner Corporation adds Kantar Health
After no updates in the M&A market for more than five years, according to results in our Healthcare Deal Database, Cerner Corporation (NASDAQ: CERN) is back with a new deal. The digital health company announced it is acquiring Kantar Health for $375 million in cash from Kantar Group. Kantar Group is a portfolio company of Bain Capital. Kantar Health is a data analytics and real-world evidence and commercial research consultancy serving the life science industry. Cerner offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs. Kantar Health’s proprietary... Read More »
BayMark Health Announces Three Deals
BayMark Health Services announced a trio of deals last week alone, doubling its transaction count for 2020, based on results from Healthcare Deals Database. With the backing of private equity firm Webster Equity Partners, the nationwide behavioral health provider acquired three new providers across three states for an undisclosed sum. For the first deal, BayMark Health acquired Portland, Maine- based Liberty Bay Recovery Center, a residential treatment facility (59 beds) that offers treatment for a variety of addictions including not only opioids but also alcohol, cocaine, methamphetamine, prescription drugs and other substances. It provides multiple levels of care including residential,... Read More »
Royal Philips Buys BioTelemetry
The medical device giant Royal Philips (NYSE: PHG) is back with a new deal, adding BioTelemetry, Inc. (NYSE: BEAT). The deal is valued at $2.8 billion, consisting of $72.00 per share in cash, or a 16.5% premium to BEAT’s closing price on December 17, 2020. BioTelemetry, formerly known as CardioNet, is a leading provider of remote cardiac diagnostics and monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring and original equipment manufacturing for healthcare and clinical research customers. BioTelemetry generated an annualized 2020 revenue of $458 million and annualized 2020 EBITDA of $92.3 million. The acquisition is a strong fit with... Read More »
Tenet Healthcare Sells Urgent Care Business
Tenet Healthcare Corporation (NYSE: THC) is having a busy holiday season. Early in December, the Texas-based health system purchased a portfolio of 45 ambulatory surgery centers (ASCs) from SurgCenter Development for $1.1 billion. Now, Tenet Healthcare is unloading a bulk of its urgent care platform in a deal valued at $80 million in order to focus on its ASC business. FastMed Urgent Care, backed by ABRY Partners and BlueMountain Capital Management, is buying Tenet’s platform, which is operated under the CareSpot and MedPost brands and managed by Tenet’s United Surgical Partners International subsidiary. The platform has 87 centers in Arizona and Texas. Tenet... Read More »
Health Care M&A Deals, December 18, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is AstraZeneca plc’s acquisition of Alexion Pharmaceuticals, Inc. for $39 billion. Alexion is a global biopharmaceutical company that has pioneered complement inhibition for a broad spectrum of immune-mediated rare diseases caused by uncontrolled activation of the complement system, a vital part of the immune system. Alexion’s expertise... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
